Migration Summary - Content

Example (Confluence API)

Displaying 1 - 116 of 116

Event

Displaying 211 - 220 of 401
Event Date
CDISC Public Webinar - PTSD Therapeutic Area User Guide Public Review -
SCDM 2017 Annual Conference -
2017 China Interchange -
Public Courses in Beijing, China -
CDISC Public Webinar - Japanese SDTMIG v 3.2 Public Review and JIRA Demonstration -
CDISC Public Webinar - Huntington's Disease Therapeutic Area User Guide Public Review -
CDISC Members Only Mini-Training Series - Governance for Data Capture Standards -
CDISC Public Webinar Series - CDISC Evolution -
CDISC Members Only Mini-Training Series - Demystifying Biomarkers -
2017 Japan Interchange -

Newsletter Article

Displaying 211 - 220 of 486
French User Network Gathers for a Virtual Meeting Second Quarter 2020
German User Network Second Quarter 2019
German User Network
German User Network
German User Network
German User Network
German User Network
German User Network
German User Network - Highlights from the September Meeting Fourth Quarter 2019
German-Speaking User Network: Monthly Meeting Update Fourth Quarter 2020

News

Displaying 61 - 66 of 66

Testimonials

Displaying 71 - 73 of 73

Knowledge Base

Displaying 1 - 56 of 56
A Short History of CDISC and SAS Transport Files Yes
Are These Findings Just Repeats or Were They Scheduled at Time Points? Yes
Assessing Causality Yes
Avoiding SDTM and ADaM Dataset and Variable Name Conflicts Yes
Can I add this variable to my SDTMIG dataset? Yes
CDISC ADaM Phases, Periods, and Subperiods: A Case Study No
CDISC-Annotated CRF Repository in Japanese Yes
Changing Event Severity Yes
Concept Maps for a Finding with Increasing Levels of Detail Yes
Concept Maps for Adverse Events with Increasing Levels of Detail Yes
Concept Maps for Substance Administration with Increasing Levels of Detail Yes
Considerations for Using CDISC Standards in Observational Studies Yes
Controlled Terminology: FAQs Yes
Country Coding Yes
Do I have to use the variable labels in the SDTMIG? Yes
Does QNAM Need to Start with a Domain Code? Yes
Domain vs. Dataset: What's the Difference? Yes
Domains are Topic-based, Except When They're Based on Structure Yes
How Do I Represent a Pre-specified Finding? Yes
How should I represent whether a physical exam was performed in SDTM? Yes
Implementation of COVID-19 Pandemic Impact Standards No
IS Domain Scope Update for the SDTMIG v3.4: A Development History and the Difficulties of Standardizing Complicated Biological Processes Yes
LOINC and the SDTM Yes
Making Clinical Data Acquisition Standards Harmonization (CDASH) Electronic Case Report Forms Available on the REDCap Shared Data Instrument Library No
Making Sense of the Various ADaM Documents Yes
Oncology Disease Response (RS) Supplements Yes
Pre-specified Events and Pre-specified Findings Yes
Providing Review-Ready Results in SDTM Yes
QA Knowledge Base No
SDTM and CDASH: Why You Need Both Yes
SDTM Structure Diagrams Yes
SDTM Timing Variables for Pre-study Findings Yes
Sex and Gender Yes
Special Values: "MULTIPLE" and "OTHER" Yes
Standardized Lab Units Yes
Study Subject Site Transfers Example Yes
Study Subject vs. Experimental Unit Yes
Subject Visits and COVID-19 Yes
TAUG Examples of SDTM Domains Yes
Test Academic No
Test Academic - Masquerade No
The Magic that Happens between CDASH and SDTM Yes
Translating CDASH "PRIOR" and "ONGO" to SDTM relative timing variables Yes
UCUM and CDISC Codelists Yes
Use of Fast Healthcare Interoperability Resources (FHIR) in the Generation of Real World Evidence (RWE) Yes
Use of FHIR in Clinical Research: From Electronic Medical Records to Analysis Yes
Use of HL7 FHIR as eSource to Pre-populate CDASH Case Report Forms using a CDISC ODM API Yes
Variable Metadata Has Changed in SDTM v2.0. How Does This Affect SDTMIG v3.4? Yes
What Do We Mean When We Say Provisional? Yes
When Did That Happen? A Brief Guide to Representing Timing in SDTM. Yes
When Would I Use ISO8601 Interval Format? Yes
Where Does My Lab Data Go in SDTMIG v3.4? Yes
Why Are Certain SDTM Variables "Not for Use in Human Clinical Trials"? Yes
Why is an Image like a Specimen? Yes
Why Not Just Use SNOMED? Yes
Why Would a Standards Development Organization Make Non-standard Variables Available on their Website? Yes

Resource

Displaying 41 - 48 of 48

Therapeutic Area Version

Displaying 71 - 73 of 73

Standard Version

Displaying 131 - 138 of 138

Company

Displaying 211 - 220 of 423
Membership Level Company Address
Korea Institute of Toxicology Gold

141 Gajeong-ro
Yuseong-gu
Daejeon
34114
South Korea

Kyoto University Hospital Gold

54 Shogoin Kawara-cho, Sakyo-ku
Sakyo-ku, Kyoto
606-8507
Japan

Kyowa Kirin Co., Ltd Gold

Tokyo, Tokyo
100-8185
Japan

Kyushu University Hospital Gold

3-1-1 Maidashi
Higashi-ku, Fukuoka
812-8582
Japan

Lantheus Holdings Gold

331 Treble Cove Rd. N.
Billerica, MA 01862
United States

Leap Therapeutics, Inc. Gold

47 Thorndike Street, B1-1
Cambridge, MA 02141
United States

LEO Pharma A/S Gold

United States

LFB Biotechnologies Gold

3 avenue des Tropiques – BP 50052
91942 Courtaboeuf Cedex
France

Liaoning Yeedo Medical Data Technology Co., Ltd. Gold

No. 2-1, Shiji Road
Shenyang Shi
Liaoning Sheng, 110018
China

Lifebit Biotech Ltd Gold

Office 4 219 Kensington High Street
London
W8 6BD
United Kingdom

Courses

Displaying 41 - 49 of 49

Instructors

Displaying 41 - 44 of 44

Team

Displaying 51 - 55 of 55
Structure Not Ready